Recent Clinical and Molecular Advances for the Classification of Myelodysplastic Neoplasms.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2022.7088
Abstract: Several major updates have recently occurred for the NCCN Guidelines for Myelodysplastic Syndromes (MDS) based on a number of prominent articles that have particular clinical and biologic impact for the field. These changes, which have… read more here.
Keywords: classification; molecular advances; advances classification; classification myelodysplastic ... See more keywords